Published in J Clin Pathol on August 01, 1987
Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes. J Clin Pathol (1992) 1.14
Detection of single copies of Epstein-Barr virus in paraffin wax sections by non-radioactive in situ hybridisation. J Clin Pathol (1991) 0.95
Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1. Br J Cancer (2015) 0.91
DNA hybridisation of routinely processed tissue for detecting HPV DNA in anal squamous cell carcinomas over 40 years. J Clin Pathol (1990) 0.88
Use of immunocytochemistry and biotinylated in situ hybridisation for detecting measles virus in central nervous system tissue. J Clin Pathol (1990) 0.85
Improved detection of HBV DNA by PCR after microwave treatment of serum. Nucleic Acids Res (1991) 0.84
Localization of cytomegalovirus DNA in plastic-embedded sections by in situ hybridization. A methodologic study. Am J Pathol (1989) 0.77
In situ hybridisation of EBV DNA-DNA hybrids using wet heat in polypropylene containers. J Clin Pathol (1992) 0.75
Enzymatic synthesis of biotin-labeled polynucleotides: novel nucleic acid affinity probes. Proc Natl Acad Sci U S A (1981) 12.44
Detection of viral genomes in cultured cells and paraffin-embedded tissue sections using biotin-labeled hybridization probes. Virology (1983) 7.54
Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc Natl Acad Sci U S A (1969) 5.56
Actin gene expression visualized in chicken muscle tissue culture by using in situ hybridization with a biotinated nucleotide analog. Proc Natl Acad Sci U S A (1982) 4.00
Widespread presence of histologically occult cytomegalovirus. Hum Pathol (1984) 3.45
Viral diagnosis by in situ hybridization. Description of a rapid simplified colorimetric method. Am J Surg Pathol (1986) 2.01
Human and viral gene detection in routine paraffin embedded tissue by in situ hybridisation with biotinylated probes: viral localisation in herpes encephalitis. J Clin Pathol (1986) 1.45
Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet (1984) 1.42
In situ hybridization for the detection of cytomegalovirus (CMV) infection. Application of biotinylated CMV-DNA probes on paraffin-embedded specimens. Virchows Arch A Pathol Anat Histopathol (1986) 1.11
Detection of viral DNA and RNA by in situ hybridization. J Histochem Cytochem (1986) 1.05
Detection of cytomegalovirus by DNA-DNA hybridization employing probes labelled with 32-phosphorus or biotin. J Virol Methods (1985) 0.85
The p53 pathway. J Pathol (1999) 6.79
Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics (1993) 4.86
Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature (1989) 4.72
The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res (1994) 3.28
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol (1991) 2.71
Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet (1986) 2.66
Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med (1990) 2.57
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer (1991) 2.52
Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology (1993) 2.52
p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! J Pathol (1994) 2.41
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology (1991) 2.32
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol (1993) 2.07
Multiplex PCR of three dinucleotide repeats in the Prader-Willi/Angelman critical region (15q11-q13): molecular diagnosis and mechanism of uniparental disomy. Hum Mol Genet (1993) 2.02
p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet (1991) 1.95
Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet (1999) 1.93
The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol (1997) 1.86
Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet (1983) 1.82
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol (1987) 1.80
The frequency of uniparental disomy in Prader-Willi syndrome. Implications for molecular diagnosis. N Engl J Med (1992) 1.78
Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology (1988) 1.76
Obese children show hyperactivation to food pictures in brain networks linked to motivation, reward and cognitive control. Int J Obes (Lond) (2010) 1.75
Do we really need a higher necropsy rate? Lancet (1999) 1.71
Breakage in the SNRPN locus in a balanced 46,XY,t(15;19) Prader-Willi syndrome patient. Hum Mol Genet (1996) 1.70
Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet (1993) 1.68
Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene (1995) 1.62
Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med (1995) 1.60
Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol (1991) 1.58
Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci (1995) 1.57
Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp Cell Res (2001) 1.57
The complexities of proliferating cell nuclear antigen. Histopathology (1992) 1.57
Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet (2006) 1.54
Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem J (1995) 1.49
The epidermal growth factor receptor in human pancreatic cancer. J Pathol (1992) 1.47
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol (1991) 1.46
Koch's postulates revisited. J Pathol (1991) 1.46
The p53 response to ionising radiation in adult and developing murine tissues. Oncogene (1996) 1.46
Ki67--structure, function, and new antibodies. J Pathol (1992) 1.45
APC expression in normal human tissues. J Pathol (1997) 1.44
Comparison of manual data coding errors in two hospitals. J Clin Pathol (1986) 1.42
Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay. J Clin Microbiol (1993) 1.41
Molecular cytogenetics of Prader-Willi and Angelman syndromes. Lancet (1991) 1.40
The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology (1993) 1.40
Trisomy 18 mosaicism in a 24-year-old white woman with normal intelligence and skeletal abnormalities. Am J Med Genet (1994) 1.39
Identification of the antigen recognized by the monoclonal antibody BU31 as lamins A and C. J Pathol (1996) 1.38
The p53 tumour suppressor gene. Br J Surg (1998) 1.37
Prenatal diagnosis and carrier detection of a cryptic translocation by using DNA markers from the short arm of chromosome 5. Am J Hum Genet (1989) 1.34
Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology (1992) 1.33
New marker of B lymphocytes, MB2: comparison with other lymphocyte subset markers active in conventionally processed tissue sections. J Clin Pathol (1987) 1.30
Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology (1992) 1.30
Comparison of X-chromosome inactivation patterns in multiple tissues from human females. J Med Genet (2007) 1.25
Do some patients with Seckel syndrome have hematological problems and/or chromosome breakage? Am J Med Genet (1987) 1.23
Expression of the 'dead box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. J Pathol (1998) 1.23
An infant with deletion of the distal long arm of chromosome 15 (q26.1----qter) and loss of insulin-like growth factor 1 receptor gene. Am J Med Genet (1991) 1.23
Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int (1987) 1.22
Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer (2000) 1.21
Do septins have a role in cancer? Br J Cancer (2005) 1.20
Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol (1989) 1.18
Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology (1991) 1.17
The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med (2000) 1.16
Fibronectin in disease. J Pathol (1984) 1.16
MDM2--arbiter of p53's destruction. Trends Biochem Sci (1997) 1.15
Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele. Am J Med Genet (1997) 1.15
Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci (1996) 1.14
Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res (2000) 1.12
Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues. Am J Pathol (1996) 1.12
Meniscal ossicle: radiographic and MR imaging findings. Radiology (1995) 1.12
Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease. Histopathology (1989) 1.11
Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest (1993) 1.10
Enteroendocrine cell hyperplasia, carcinoid tumours and adenocarcinoma in long-standing ulcerative colitis. Histopathology (1986) 1.10
Do aggressive subclones within primary colorectal cancer give rise to liver metastases? Int J Colorectal Dis (1989) 1.10
Intercontinental karyotypic differentiation of Chironomus entis Shobanov, a Holarctic member of the C. plumosus group (Diptera, Chironomidae). Genome (2000) 1.09
Enzyme-linked immunosorbent assay and enzyme-linked coagulation assay for detection of Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes with dual-label antibodies. J Clin Microbiol (1994) 1.08
Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens. Cancer Res (1994) 1.08
Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity. Int J Obes (Lond) (2011) 1.07
A 26-month-old child with Marden-Walker syndrome and pyloric stenosis. Am J Med Genet (1987) 1.07
Demonstration of DNA damage/repair in individual cells using in situ end labelling: association of p53 with sites of DNA damage. J Pathol (1995) 1.07
Metacarpophalangeal pattern profile analysis in Prader-Willi syndrome. Clin Genet (1982) 1.07
p53--integrating the complexity. J Pathol (1996) 1.06
Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. Int J Obes (Lond) (2008) 1.05
The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol (2000) 1.05
Microarray analysis of gene/transcript expression in Prader-Willi syndrome: deletion versus UPD. J Med Genet (2003) 1.04
No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD). J Med Genet (2002) 1.04
Brief report: non-random X chromosome inactivation in females with autism. J Autism Dev Disord (2005) 1.04
Distinct 15q genotypes in Russell-Silver and ring 15 syndromes. Am J Med Genet (1996) 1.04
The relationship between compulsive behaviour and academic achievement across the three genetic subtypes of Prader-Willi syndrome. J Intellect Disabil Res (2007) 1.03
Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogenet Genome Res (2009) 1.03
Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations. Am J Ment Retard (1999) 1.02
Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology (1993) 1.02
Epithelial tumors metastatic to the uterine cervix. A study of 33 cases and review of the literature. Cancer (1986) 1.01
Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. J Clin Pathol (1987) 1.01
Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. Gut (1995) 1.01
Antibodies to T cell antigen receptor beta chain families detect monoclonal T cell proliferation. Lancet (1986) 1.00
A new method of hydrolysis for the identification of acid glycoprotein. Med Lab Technol (1973) 0.97
Adenovirus keratitis: a role for interleukin-8. Invest Ophthalmol Vis Sci (2000) 0.96
An anthropometric study of 38 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet (1987) 0.96
Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tract. Regul Pept (1983) 0.95